INTERACTOR1 | INT1_HGNC_ID | INTERACTOR2 | INT2_HGNC_ID | INTERACTION_TYPE | CSC_METHOD | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | INTERACTION_METHOD | EXPRESSION_LEVEL | PUBMED_ID |
---|
JPT2 | 14137 | AR | 644 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | COL14A1 | 2191 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | FGFR2 | 3689 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay followed by qPCR | NA | 29249663
|
JPT2 | 14137 | FOXP1 | 3823 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | HOXA11 | 5101 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | MUC6 | 7517 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | MYC | 7553 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | PAX1 | 8615 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | RGS2 | 9998 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | STAT3 | 11364 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay followed by qPCR | NA | 29249663
|
JPT2 | 14137 | TBX5 | 11604 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | VDR | 12679 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | GUSBP1 | 13670 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | FGD6 | 21740 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | ZNF507 | 23783 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | SORBS2 | 24098 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | TRAPPC13 | 25828 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | CWH43 | 26133 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|
JPT2 | 14137 | ZNF385B | 26332 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Carcinoma | SUM159 | ChIP seq assay | NA | 29249663
|